Blood-based biomarkers for Alzheimer's disease diagnosis: a joint position paper from the Italian Societies of Neurology (SIN) and of Clinical Biochemistry and Clinical Molecular Biology - Laboratory
3 hours ago
- #Biomarkers
- #Diagnosis
- #Alzheimer’s disease
- Joint position paper on blood-based biomarkers for Alzheimer's disease diagnosis by Italian Societies of Neurology (SIN), Clinical Biochemistry and Clinical Molecular Biology - Laboratory Medicine (SIBioC), and SINdem.
- Focus on biomarkers like P-tau217 and P-tau217/Aβ42 for clinical implementation in Italy.
- No ethical approval required as the paper does not involve patient data or human materials.
- Authors disclose various competing interests, including advisory roles, speaker fees, and research grants from pharmaceutical companies.
- No external funding or industry partners involved in the manuscript development.
- References include studies on plasma phospho-tau217 for Alzheimer's diagnosis and dementia prevalence in Europe.